Moreover, our data demonstrated the upregulation of several adenylate cyclases (ADCYs) and their downstream targets (e.g., EPAC2, MAPK8, and RRAS2) in RP retinas, with no detected downregulations in these components. This evidence concerns the gene ADCY1 and retinitis pigmentosa 1.